DDIT4 and acute myeloid leukemia: In this retrospective study, we demonstrated that up‐regulated DDIT4 expression adversely affects the prognosis of AML patients who underwent chemotherapy alone, but not those who were treated with allo‐HSCT, suggesting that allo‐HSCT may neutralize its negative prognostic impact.